Metabolic syndrome and the pathophysiological role of adiponectin;Síndrome metabólico y adiponectina

Informe Medico

Volumn 10, Issue 4, 2008, Pages 195-201

  Lima, Marcos M ^a   Rosa, Francisco J ^a   Marin, Abigail ^a  

^a Universidad de Oriente Nucleo Bolivar   (Venezuela)

Author keywords

Adipocyte; Adiponectin; Metabolic syndrome

Indexed keywords

EID: 49849093924     PISSN: 13169688     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Matsuzawa Y, Funahashi T, Kihara S, Shimomura I. Adiponectin and metabolic syndrome. Arterioscler. Thromb Vasc Biol 2004;24:29-33.
2. Reaven G. The metabolic syndrome: requiescat in pace. Clin Chem 2005;51:931-938.
3. Reaven C. A role for insulin in etiology and course of hypertension. Lancet; 1999;357:435-437.
4. Lima M, López G, Marin A, Rosa F. Determinación de niveles de adiponectina en pacientes con síndrome metabólico y su correlación con el HOMA. Med Int (Caracas) 2007;23:117-123.
5. Lihn A, Pedersen S, Richelsen B. Adiponectin: action, regulation and association to insulin sensitivity. Obes Rev 2005; 6:13-21.
6. Gonzalez M, Bastidas B, Ruíz B, Godínez S, Panduro A. Funciones endocrines de la célula adiposa. Rev Endocrin Nutr 2002;10:140-146.
7. Chandran M, Phillips S, Ciaraldi T, Henry R. Adiponectin: more than just another fat cell hormone?. Diab Care 2003;26:2442-2450.
8. Shetty G, Economides P, Horton E, Mantzoros C, Veves A. Circulating adiponectin and resistin levels in relation to metabolic factors, inflammatory markers, and vascular reactivity in diabetic patients and subjects at risk for diabetes. Diab Care 2004;27:2450-2457.
9. Maahs DM, Ogden LG, Kinney GL, Wadwa P, Snell-Bergeon JK, Dabelea D, Hokanson JE, Ehrlich J, Eckel RH, Rewers M. Low plasma adiponectin levels predict progression of coronary artery calcification. Circulation 2005;111:747-753.
10. Kubota N, Terauchi Y, Yamauchi T, Kubota T, Moroi M, Matsui J, Eto K, Yamashita T, Kamon J, Satoh H, Yano W, Froguel P, Nagai R, Kimura S, Kadowaki T, Noda T. Disruption of adiponectin causes insulin resistance and neointimal formation. J Biol Chem 2002;277:25863-25866.
11. Ouchi N, Kihara S, Funahashi T, Nakamura T, Nishida M, Kumada M, Okamoto Y, Ohashi K, Nagaretani H, Kishida K, Nishizawa H, Maeda N, Kobayashi H, Hiraoka H, Matsuzawa Y. Reciprocal association of C-reactive protein with adiponectin in blood stream and adipose tissue. Circulation 2003;107:671-674.
12. Kern PA et al. Adiponectin expression from human adipose tissue: relation to obesity, insulin resistance, and tumor necrosis factor-α expression. Diabetes 2003;52:1 779-1785.
13. Lindsay RS, Funahashi T, Hanson RL, Matsuzawa Y, Tanaka S, Tataranni PA, Knowler WC, Krakoff J. Adiponectin and development of type 2 diabetes in the Pima Indian population. Lancet 2002;360:57-58.
14. Bacha F, Saad R, Gungor N, Arslanian S. Adiponectin in youth. Diab Care 2004;27:547-552.
15. Grundy SM. Obesity, metabolic syndrome, and coronary atherosclerosis. Circulation 2002;105:2696-2698.
16. McGill HC, McMahan A, Herderick EE, Zieske AW, Malcom GT, Tracy RE, Strong J P. Obesity accelerates the progression of coronary atherosclerosis in young men. Circulation 2002;105:2712-2718.
17. Contreras M. El efecto dual de Ia insulina y la arteriosclerosis. Med Int (Caracas) 2004;20:112-115.
18. Shepherd PR, Kahn BB. Glucose transporters and insulin action. Implications for insulin resistance and diabetes mellitus. N Engl J Med 1999;341:248-257.
19. Ouchi N, Kihara S, Arita Y, Maeda K, Kuriyama H, Okamoto Y, Hotta K, Nishida M, Takahashi M, Nakamura T, Yamashita S, Funahashi T, Matsuzawa Y. Novel modulator for endothelial adhesion molecules adipocyte- derived plasma protein adiponectin. Circulation. 1999;100: 2473-2476.
20. Ouchi N, Kihara S, Arita Y, Okamoto Y, Maeda K, Kuriyama H, Hotta K, Nishida M, Takahashi M, Muraguchi M, Ohmoto Y, Nakamura T, Yamashita S, Funahashi T, Matsuzawa Y. Adiponectin, an adipocyte- derived plasma protein, inhibits endothelial NF- kB signaling through a cAMP - dependent pathway. Circulation 2000;102:1296-1301.
21. Arita Y, Kihara S, Ouchi N, Maeda K, Kuriyama H, Okamoto Y, Kumada M, Hotta K, Nishida M, Takahashi M, Nakamura T, Shimomura I, Muraguchi M, Ohmoto Y, Funahashi T, Matsuzawa Y. Adipocite- derived plasma protein adiponectin acts as a platelet- derived growth factor- bb- binding protein and regulates growth factor- induced common postreceptor signal in vascular smooth muscle cell. Circulation 2002; 105:2893-2898.
22. Okamoto Y, Kihara S, Ouchi N, Nishida M, Arita Y, Kumada M, Ohashi K, Sakai N, Shimomura I, Kobayashi H, Terasaka N, Inaba T, Funahashi T, Matsuzawa Y. Adiponectin reduces atherosclerosis in apolipoprotein E- deficient mice. Circulation 2002;106:2767-2770.
23. Kumada M, Kihara S, Ouchi N, Kobayashi H, Okamoto Y, Ohashi K, Maeda K, Nagaretani H, Kishida K, Maeda N, Nagasawa A, Funahashi T, Matsuzawa Y. Adiponectin specifically increased tissue inhibitor of metalloproteinase - 1 through interleukin - 10 expression in human macrophages. Circulation 2004;109:2046-2049.